“白血病芯片”精准测试CAR-T疗法效果

Core Viewpoint - The development of the "leukemia chip" by the University of Pennsylvania and NYU Tandon School of Engineering represents a significant advancement towards personalized treatment for leukemia and other cancers, marking a new phase in personalized immunotherapy research [1]. Group 1 - The "leukemia chip" is a micro-laboratory device designed to test the effectiveness of CAR-T therapy [1]. - This innovation has been published in the latest issue of Nature Biomedical Engineering, highlighting its scientific credibility and potential impact [1]. - The collaboration between two prestigious institutions underscores the importance of interdisciplinary research in advancing cancer treatment [1].